Table 5 Trials involving cryotherapy, surgical and combination therapy of genital warts
|
Reference |
Patients |
Design |
Clearance |
Recurrence/side effects |
|
Stone KM, 1990 30 |
450 |
Randomized Control |
Surgical excision showed complete clearance of warts in
94% and 71% after 6 weeks and 3 months |
Recurrence |
|
Simmons, PD 1981 31 |
42 |
Randomized Control |
No significant difference over 3 months follow-up comparing cry therapy versus electrocautery |
No data |
|
Eron et al, 1993 33 |
97 |
Randomized control, double blind |
Interferon alpha-2a had no benefit as an adjuvant to
cryotherapy. |
28% of interferon recipients and 43% of placebo recipients
experienced recurrences. At six months follow-up, 69% interferon and 73%
placebo recipients experienced recurrences. |
|
Handley et al1991 34 |
91 |
Randomized control |
At eight weeks subcutaneous IFN alpha 2a combined with
cryotherapy showed 60.7% clearance versus 67.9% clearance with cryotherapy
alone. |
Recurrence at three months was 50% and 37.5% of patients
in the IFN and placebo groups respectively |
|
Abdullah et al 1993 35 |
86 |
Randomized controlled |
86% clearance of warts in patients who received
cryotherapy vs 70% of patients who received trichloracetic acid. |
No data on recurrences. Ulcerations at the site of application developed in 30% of
the TCA treated patients |
|
Damstra et al 1991 36 |
134 |
Clinical trial |
Showed clearance in 83% within 4 weeks and 96% after 6
weeks with cryotherapy versus 13% and 45% after 4 weeks and 6 weeks,
respectively in the control |
No data |
|
Godley et al 1987 37 |
130 |
Randomized Control |
Showed clearance in 88% of patients treated with
cryotherapy versus 81% of those treated with TCAA |
Recurrence found in 36% of patients treated with TCAA and
in 39% of those treated with cryotherapy. |